E-Buy Home, Inc. (EBYH)

[funnyG986]

EBYH merger co 1st DD notes; must READ!

EBYH clean shell reverse merger with Strainsforpains, Inc

Information updated on otcmarkets.com on 08/09/2016; Tiny OS 446K verified as well
Business Description
Strainsforpains, Inc. is a medical marijuana recommendation engine headquartered in New York City. SFPC primary focus will be to match medical marijuana users with the appropriate cannabis strains to treat their specific diseases or symptoms.

Verified Company Profile 08/09/2016

Merger co website
http://strainsforpains.com/

Company active on NYSOS
https://www.bizpedia.info/d/strainsforpains-inc

A few notes from their website

Strainsforpains will work with Mount Sinai Hospital physicians on pain management education. Strainsforpains is collaborating with University of Vermont professors on company APP. Company management to attend several medical cannabis shows in 2016.

Company News Letter
https://www.dropbox.com/s/c2ehcpizf6t1bw2/SFP%20newsletter.pdf?dl=0

Company Executives
https://www.dropbox.com/s/95rkbttglmjze51/StrainsForPains%20Executive%20summary.pdf?dl=0

Dr. Michael Stern MD

Michael Stern graduated from medical school in 1973 and since 1983 has been a board-certified urologist and urological surgeon. Dr. Stern served as an adjunct clinical faculty member at Bast-yr University School of Naturopathic Medicine for 11 years (1995 --2006). Dr. Stern operates the Northwest Healthy Options Clinic in Seattle, Washington. Dr. Stern continues advising patients on lifestyle issues and alternative healthy treatments for a wide variety of diseases, including medical cannabis.

Dr. Bindiya Moorjani Neuroiscientist

Dr. Bindiya Moorjani was a awarded a Ph. D. in biomedical sciences from the Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York University. Dr. Moorjani has authored several scientific studies that have been published in scientific journals. She did major studies on Serotonin. From 1993 through 1999, Dr. Moorjani was a graduate researcher at the Mount Sinai School of Medicine in the doctoral program concentrating on neurobiology.


Company Revenue Projection with Artificial Intelligence Cloud solution
The large number of pharmacological combinations are already identified with the company's proprietary systems. We will position our New York based Company as a WebMD-like hub for consumer and industry data. We will provide a secure cloud-based platform with robust artificial intelligence (“A.I.”) and data mining capabilities at its core.The company’s revenues will come from selling its scientific informational data base to physicians,dispensaries,and patients by subscription and through advertising.The Company projects over 2 million in revenues in 2016 and 36 million in revenues by 2019.